Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above
PHASE3
This protocol was designed to evaluate the safety, clinical tolerability an...
Status
Completed
Location
University of Rostock, Department Tropical Medicine and Infectious Diseases
A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.
PHASE1
The objective of this study is to evaluate the safety and immunogenicity of...